When should we add a diverting loop ileostomy to laparoscopic ileocolic resection for primary Crohn's disease?
- 1 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 35 (6), 2543-2557
- https://doi.org/10.1007/s00464-020-07670-w
Abstract
Background The aims of this study were to determine risk factors for morbidity associated with laparoscopic ileocolic resection (LICR) for Crohn's disease (CD) and whether the addition of a diverting ileostomy is associated with reduced morbidity. Methods Patients undergoing LICR for primary CD at our institution from 2005 to 2015 included in a prospectively maintained database were assessed. The decision to perform a diverting ileostomy was left at the discretion of the operating surgeon. Demographics, disease-related, and treatment-related variables were evaluated using univariate and multivariate analyses as possible factors associated with diverting ileostomy creation and 30-day perioperative septic complications (anastomotic leaks and/or abscess). Use of any immunosuppressive medication was defined as use of steroids, biologics, and immunomodulators either alone or in combination. Results For 409 patients, mortality was nil, overall morbidity rate was 40.6%, conversion rate 9.3%, and septic morbidity rate 7.6%. A diverting stoma was created in 22% of cases and was independently associated with BMI< 18.5 kg/m(2) (P = 0.001), low serum albumin levels (P = 0.006), and longer operative time (P = 0.003). Use of any immunosuppressive medication was the only variable independently associated with septic complications, both in the overall population (OR 2.7, P = 0.036) and in the subgroup of undiverted patients (OR 3.1, P = 0.031). There was no association between septic morbidity and ileostomy creation, anastomotic configuration, penetrating disease, combined procedures (other resection or strictureplasty), BMI, albumin levels, and operative times. Conclusions LICR is safe in selected cases of complex penetrating disease, including when combined procedures are necessary. Our data are unable to prove that a diverting stoma is associated with reduced morbidity.This publication has 48 references indexed in Scilit:
- Laparoscopic surgery for Crohn’s disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgeryBMC Surgery, 2013
- Risk factors for complications after bowel surgery in Korean patients with Crohn's diseaseJournal of the Korean Surgical Society, 2012
- A laparoscopic approach reduces short‐term complications and length of stay following ileocolic resection in Crohn’s disease: an analysis of outcomes from the NSQIP databaseColorectal Disease, 2011
- Laparoscopic versus Open surgery for small bowel Crohn's diseaseEmergencias, 2011
- Laparoscopic resection for Crohn’s disease: an experience with 335 casesSurgical Endoscopy, 2009
- Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: Follow-up of a prospective randomized trialSurgery, 2008
- Defunctioning Stoma Reduces Symptomatic Anastomotic Leakage After Low Anterior Resection of the Rectum for Cancer: A Randomized Multicenter TrialAnnals of Surgery, 2008
- Defunctioning Stoma Reduces Symptomatic Anastomotic Leakage After Low Anterior Resection of the Rectum for CancerAnnals of Surgery, 2007
- Laparoscopic-Assisted Versus Open Ileocolic Resection for Crohn??s DiseaseAnnals of Surgery, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004